Since the phenotype of so-called cancer stem-like cells (CSCs) is a known feature of many chemotherapy-resistant tumors, it was then investigated whether MYC and MCL1 contributed to the enrichment of CSCs. The gene discussed is MCL1; the disease is cancer.